Robot + Active Learning Program(RT-ALPS) for Stroke

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Stroke+1 MoreRobot + Active Learning Program(RT-ALPS) - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will study the effects of robot-assisted therapy on post-stroke patients' ability to use their affected arm in every day activities.

Eligible Conditions
  • Stroke

Treatment Effectiveness

Study Objectives

6 Primary · 16 Secondary · Reporting Duration: Baseline and 10 weeks

Baseline and 10 weeks
Change from Baseline Canadian Occupational Performance Measure (COPM) at 10 weeks
Change from Baseline Confidence in Arm and Hand Movement (CAHM) Scale at 10 weeks
Change from Baseline Fugl-Meyer Assessment (FMA) at 10 weeks
Change from Baseline Home-based Accelerometry: Wearable Sensors at 10 weeks
Change from Baseline Modified Ashworth Scale (MAS) at 10 weeks
Change from Baseline Motor Activity Log (MAL) Amount of Use (AOU) at 10 weeks
Change from Baseline Motor Activity Log (MAL) Quality of Movement (QOM) at 10 weeks
Change from Baseline Stroke Impact Scale (SIS) at 10 weeks
Change from Baseline Wolf Motor Function Test (WMFT) Functional Ability Score (FAS) at 10 weeks
Change from Baseline Wolf Motor Function Test (WMFT) Strength (kg) at 10 weeks
Change from Baseline Wolf Motor Function Test (WMFT) Time at 10 weeks
Baseline and 6 weeks
Change from Baseline Canadian Occupational Performance Measure (COPM) at 6 weeks
Change from Baseline Confidence in Arm and Hand Movement (CAHM) Scale at 6 weeks
Change from Baseline Fugl-Meyer Assessment (FMA) at 6 weeks
Change from Baseline Home-based Accelerometry: Wearable Sensors at 6 weeks
Change from Baseline Modified Ashworth Scale (MAS) at 6 weeks
Change from Baseline Motor Activity Log (MAL) Amount of Use (AOU) at 6 weeks
Change from Baseline Motor Activity Log (MAL) Quality of Movement (QOM) at 6 weeks
Change from Baseline Stroke Impact Scale (SIS) at 6 weeks
Change from Baseline Wolf Motor Function Test (WMFT) Functional Ability Score (FAS) at 6 weeks
Change from Baseline Wolf Motor Function Test (WMFT) Strength (kg) at 6 weeks
Change from Baseline Wolf Motor Function Test (WMFT) Time at 6 weeks

Trial Safety

Trial Design

2 Treatment Groups

Robot-Assisted Therapy (RT)
1 of 2
Robot + Active Learning Program(RT-ALPS)
1 of 2

Active Control

Experimental Treatment

15 Total Participants · 2 Treatment Groups

Primary Treatment: Robot + Active Learning Program(RT-ALPS) · No Placebo Group · N/A

Robot + Active Learning Program(RT-ALPS)
Behavioral
Experimental Group · 1 Intervention: Robot + Active Learning Program(RT-ALPS) · Intervention Types: Behavioral
Robot-Assisted Therapy (RT)
Behavioral
ActiveComparator Group · 1 Intervention: Robot-Assisted Therapy (RT) · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline and 10 weeks

Who is running the clinical trial?

Spaulding Rehabilitation HospitalLead Sponsor
125 Previous Clinical Trials
10,531 Total Patients Enrolled
24 Trials studying Stroke
1,035 Patients Enrolled for Stroke
American Occupational Therapy FoundationOTHER
10 Previous Clinical Trials
424 Total Patients Enrolled
4 Trials studying Stroke
114 Patients Enrolled for Stroke
Paolo Bonato, PhDStudy ChairSpaulding Rehabilitation Hospital
21 Previous Clinical Trials
705 Total Patients Enrolled
10 Trials studying Stroke
317 Patients Enrolled for Stroke

Eligibility Criteria

Age 18+ · All Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you: